Executive Summary
Generated July 30, 2026
Quantum Computing
D-Wave Quantum
Strategic importance is our editorial rating of how central this entity is to the technology landscape we track; confidence reflects how well-sourced and current the underlying evidence is.
0
Chokepoint Score
no direct dependencies recorded in the graph
Steady
Momentum
insider filing activity unchanged since last check
Headquarters
Palo Alto, California, USA
Website
Employees
250 (2026, approximate)
Founded
1999
Listing
QBTS · NYSE
Market Cap
$6.00B
Revenue (TTM)
$12.44M
Price
USD16.21 (-8.93%)
Market data as of Jul 29, 2026, 11:25 AM · Source: Yahoo Finance (delayed). Not investment advice.
Overview
The longest-established quantum annealing company, now expanding into gate-model systems, which reported record Q1 2026 bookings of $33.4 million (up nearly 2,000% year-over-year) including a $20 million system sale to Florida Atlantic University and a $10 million enterprise agreement with a Fortune 100 company, against a $588.4 million cash balance. D-Wave completed the second phase of a drug-discovery project with Shionogi, delivering a ten-fold increase in desirable drug-like molecule discovery versus classical machine learning.
Strategic Connections
- Quantum Computing: D-Wave develops quantum annealing systems and is expanding into gate-model quantum computing, publishing research on 'multi-color annealing' protocols that blur the line between the two modalities.
- Rigetti Computing: D-Wave competes with Rigetti Computing as it expands from quantum annealing into gate-model quantum computing.
Strategic Risks
- Revenue remains lumpy and dependent on a small number of large system sales per year
- Strategic pivot toward gate-model systems creates execution risk alongside the core annealing business
- Stock down 29% in July 2026 amid a broader quantum-sector selloff despite narrowing losses
Future Outlook
- System sales outlook raised to 2-3 per year on a more than doubled sales pipeline
- Shionogi drug-discovery results position D-Wave's annealing technology for further pharma/biotech partnerships
- 21-qubit gate-model simulator launching on the Leap cloud platform in September 2026
Sources
4 sources, 68% average source confidence — full citations in the Full Analyst Report.
Generated by InsightNodes — Technology Intelligence Platform. This report reflects sourced, evidence-backed information as of the dates cited above and is not investment advice.
Viewing the Executive Summary — switch to the Full Analyst Report.